Umbilical Cord-derived Mesenchymal Stem Cell Injectables for the Regeneration of Partial-thickness Rotator Cuff Tears

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age19+
SponsorKyoung Hwan Koh

About this trial

The purpose of this study is to evaluate umbilical cord-derived mesenchymal stem cell injectables for the regeneration of partial-thickness rotator cuff tears

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Adults aged 19 years or older

Shoulder pain lasting for at least 3 months

A pain visual analogue scale (VAS) score of 4 or greater

Inadequate response to sufficient conservative treatment for at least 3 months, such as medication, injection therapy, physical therapy, or exercise therapy

Disqualifiers

Receipt of subacromial injection therapy in the affected shoulder within the past 3 months

History of rotator cuff surgery on the affected shoulder within the past 6 months

Previous treatment with a stem cell therapy for the shoulder

Presence of any of the following shoulder conditions: full-thickness rotator cuff tear, obvious isolated acromioclavicular joint arthropathy, or a clear history of trauma to the shoulder joint within the past 3 months

Trial design

Design model

Parallel

Treatments tested in this trial

  • umbilical cord-derived mesenchymal stem cell

    Biological/Vaccine

    Administration of high-dose or medium-dose umbilical cord-derived mesenchymal stem cells

  • Normal Saline

    Drug

    Administration of normal saline as a placebo control.

Treatment groups

38 Participants
are divided into 3 treatment groups
Group A: High-dose groupExperimental treatment 1 intervention
Group B: Medium-Dose GroupExperimental treatment 1 intervention
Group C: Placebo ComparatorPlacebo comparator 1 intervention

Trial outcomes

Primary outcomes

1

Changes in the size of rotator cuff tears determined by MRI

The location, width (AP size), length (ML size), and depth of the rotator cuff tear will be measured on oblique coronal, axial, and sagittal MRI images where the tear is most clearly visualized. The same measurements will be performed on the corresponding planes after administration of the investigational product and compared with those obtained before administration.

Time frame
6months

Secondary outcomes

1

Shoulder pain and disability index(SPADI) Score

The Shoulder Pain and Disability Index (SPADI) is a self-administered questionnaire that consists of two dimensions, one for pain and the other for functional activities. The pain dimension consists of five questions regarding the severity of an individual's pain. Functional activities are assessed with eight questions designed to measure the degree of difficulty an individual has with various activities of daily living that require upper-extremity use. The minimum value is 0 and the maximum value is 10. "0" means no pain and "10" means the worst pain imaginable in the pain section. "0" means no difficulty and "10" means so difficult it requires help in the pain section.

Time frame
6months
2

Constant-Murley score

The Constant score assesses pain, function, ROM, and strength. Pain is allotted a maximum of 15 points, activities of daily living (function)20 points, ROM 40 points, and strength 25 points. The component scores are summated to achieve a maximum possible total score of 100.

Time frame
6months
3

Visual Analog Scale(VAS) pain

Using a ruler, the score is determined by measuring the distance (mm) on the 100mm line between the "no pain" anchor and the patient's mark, providing a range of scores from 0-100. A higher score indicates greater pain intensity.

Time frame
6months
4

Location and size of the rotator cuff tear assessed by arthroscopy

Time frame
6months

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Kyoung Hwan Koh

Lead sponsor

Asan Medical Center

Sponsor institution

This trial is not recruiting at the moment. You can still explore other options: